此内容来自:xinyabo体育

银杏生物价格的SPAC成功是这些对冲基金的好消息

Biotech公司的第一天是第一天交易,是迄今为止最近合并专用收购公司表现不佳的趋势。

Good news for the slumbering SPAC market.Shares of Ginkgo Bioworks got off to a strong start on the company’s first day of trading, rising more than 6 percent to close at $12.15 a share after the company completed its merger with the special purpose acquisition company Soaring Eagle Acquisition Corp.This

继续阅读,现在订阅高级新闻。已经订阅了订阅者?登录